All those studies highlight the importance of fully understanding the wide diversity of epigenetic mechanisms regulating EMT-TF, such as ZNF217, with the ultimate aim to design therapeutic strategies counteracting tumor progression and metastasis development. This evidence concerns the gene ZNF217 and neoplasm.